This study may additionally support the hypothesis that HFrEF is, in part, a metabolic disease with alterations in fuel signalling proteins such as FGF21 from extracardiac organs such as the liver engendering changes in cardiac energy metabolism. The gene discussed is FGF21; the disease is metabolic disease.